World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Clinical trial tests new cell therapy to manage kidney transplant rejection

Clinical trial tests new cell therapy to manage kidney transplant rejection

by admin | Apr 10, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of Wisconsin School of Medicine and Public Health – A first-of-its-kind clinical trial at the Program for Advanced Cell Therapy will examine a new method to manage kidney rejection following transplant. The Program for Advanced Cell Therapy, or...
Scientists Discover Hidden “Footprint of Death” That Could Transform How We Fight Disease

Scientists Discover Hidden “Footprint of Death” That Could Transform How We Fight Disease

by admin | Apr 9, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By La Trobe University – SciTechDaily – Scientists have uncovered a previously unknown feature of cell death that reshapes how the immune system identifies and clears dying cells. Scientists at La Trobe University have identified a previously unknown way...
Nobel Prize winners face new loss in bid for US CRISPR patents

Nobel Prize winners face new loss in bid for US CRISPR patents

by admin | Apr 8, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Blake Brittain – Reuters News – March 27 (Reuters) – A U.S. Patent Office tribunal has ruled against Nobel Prize-winning scientists Jennifer Doudna and Emmanuelle Charpentier for a second time in their dispute with ​the Broad Institute, a joint...
After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse

After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse

by admin | Apr 7, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Roswell Park Comprehensive Cancer Center – MedicalXPress – Results of a Phase I clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a lower risk of relapse and lower rates of graft-versus-host disease when...
UCLA researchers receive .9 million CIRM grant to identify drug targets for autism and schizophrenia using human stem cell models

UCLA researchers receive $13.9 million CIRM grant to identify drug targets for autism and schizophrenia using human stem cell models

by admin | Apr 6, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Tiare Dunlap – UCLA Health – A team of researchers led by UCLA’s Dr. Daniel Geschwind has received a $13.9 million grant from the California Institute for Regenerative Medicine to use human stem cell-based models to uncover the molecular and cellular...
RNA-guided CRISPR system activates gene expression

RNA-guided CRISPR system activates gene expression

by admin | Apr 3, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Alisha Willett, Purdue University – PHYS.ORG – In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally evolved gene-editing system that can activate genes, offering an advantage over...
Page 1 of 21012345...102030...»Last »

Recent Posts

  • Clinical trial tests new cell therapy to manage kidney transplant rejection
  • Scientists Discover Hidden “Footprint of Death” That Could Transform How We Fight Disease
  • Nobel Prize winners face new loss in bid for US CRISPR patents
  • After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse
  • UCLA researchers receive $13.9 million CIRM grant to identify drug targets for autism and schizophrenia using human stem cell models
  • RNA-guided CRISPR system activates gene expression
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow